glp-1 receptor agonist examples Evolution of GLP‐1 Agonists for Diabetes Treatment Glucagon-like peptide-1 receptor: mechanisms and

Curcumin induces secretion of glucagon-like peptide-1 through an oxidation-dependent mechanism

The A-Series cyclohepta[ b ]indole JWU-A021 was bioactive at nM concentrations, whereas all B-series cyclopenta[ b ]indoles were ineffective

Kubota A, Yamada Y, Hayami T, Yasuda K, Someya Y, Ihara Y, et al

ZP CON BS 20DEC2024 Zepbound and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates

2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Medications like semaglutide (Ozempic) or tirzepatide (Mounjarno or Zepbound) are GLP-1 injections that can be a helpful tool for patients who need support managing their weight or type 2 diabetes